We recently published a list of 35 Non-Tech AI Opportunities Amid DeepSeek Selloff. In this article, we are going to take a look at where Illumina, Inc.

Seventeen health systems are investing in a genomic database that could significantly drive down clinical costs. Truveta, a Washington-based software company, unveiled the Truveta Genome Project on ...

Thus far 2025 has come roaring in as far as large rounds go. Last week more than a dozen companies raised $100 million or ...

The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...

It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...

US health systems and Regeneron Genetics Center launch the Truveta Genome Project, a $320M initiative to sequence up to 10M ...

Earlier this week, health data company Truveta, which normally traffics data like patient immunizations, social determinations of health, lab tests, and pharmacy and insurance claims, announced ...

In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other stocks. In one of his latest appearances on CNBC’s Squawk on the ...

Also in the news: Neuralink, J&J, Bayer, Nvidia, Amazon Web Services, and more. Stat: Truveta Joins Drugmakers To Launch Massive Genomic Database Health data company Truveta said Monday it’s ...

After Regeneron Chief Scientific Officer George Yancopoulos, M.D., Ph.D., spent more than 25 minutes waxing about the company’s deep pipeline Monday at the J.P. Morgan Healthcare Conference ...